Physician
Neurology
Dr. Martha A. Nance, MD
|
|
Give Review
Martha Nance is an expert in the field of Neurology. Martha A. Nance is also published. She has 72 publications published. The lastest publication: "Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22.'
Publications
- Cognitive and Motor Function in Long-Duration PARKIN-Associated Parkinson Disease.
- Frequency of known mutations in early-onset Parkinson Disease: implication for genetic counseling: the consortium on risk for early onset Parkinson Disease study.
- Predictors of parkin mutations in early-onset Parkinson Disease: the consortium on risk for early-onset Parkinson Disease study.
- Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson Disease.
- Comprehensive care in Huntington's Disease: a physician's perspective.
- Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31.
- A new locus for dominant hereditary spastic paraplegia maps to chromosome 2p12.
- Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations.
- Genetic testing in inherited Ataxias.
- Association study of Parkin gene polymorphisms with idiopathic Parkinson Disease.
- Seeking clarity through the genetic lens: a work in progress.
- Parkin mutations and susceptibility alleles in late-onset Parkinson's Disease.
- Mitochondrial polymorphisms significantly reduce the risk of Parkinson Disease.
- Age at onset in two common neurodegenerative Diseases is genetically controlled.
- Huntington CAG repeat size does not modify onset age in familial Parkinson's Disease: the GenePD study.
- A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson''s Disease.
- Replication of association between ELAVL4 and Parkinson Disease: the GenePD study.
- Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.
- Preparing for preventive clinical trials: the Predict-HD study.
- Haplotypes and gene expression implicate the MAPT region for Parkinson Disease: the GenePD Study.
- Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat Disorders.
- Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington Disease.
- Complete genomic screen in Parkinson Disease: evidence for multiple genes.
- Verbal episodic memory declines prior to diagnosis in Huntington''s Disease.
- Diagnosis of patients presenting to a Huntington Disease (HD) clinic without a family history of HD.
- Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson Disease.
- The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson''s Disease: the GenePD study.
- Genetic testing of children at risk for Huntington's Disease. US Huntington Disease Genetic Testing Group.
- Characteristics of individuals with Huntington Disease in long-term care.
- Impulsive behavior and associated clinical variables in Parkinson''s Disease.
- Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher Disease.
- Anonymous predictive testing for Huntington''s Disease in the United States.
- Autosomal dominant spinocerebellar Ataxia: locus heterogeneity in a Nebraska kindred.
- Antigliadin antibodies in Huntington's Disease.
- Heterogeneity in Paget Disease of the bone.
- Clinical aspects of CAG repeat Diseases.
- The relation between depression and parkin genotype: the CORE-PD study.
- Linkage of familial amyotrophic lateral sclerosis with frontotemporal Dementia to chromosome 9q21-q22.
- Predictors of nursing home placement in Huntington Disease.
- Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's Disease: comparison to small vessel ischemic vascular dementia.
- Huntington Disease--another chapter rewritten.
- Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's Disease.
- Knowledge of genetics and attitudes toward genetic testing in two hereditary Ataxia (SCA 1) kindreds.
- Juvenile onset Huntington's Disease--clinical and research perspectives.
- Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma.
- Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph Disease.
- Hyperlipidemia and Neuropathy.
- Huntington Disease: clinical, genetic, and social aspects.
- Fetal chromosome analysis in Virginia: results and complications of 2,288 cases.
- Genetic testing for Ataxia in North America.
- Childhood-onset Ataxia: testing for large CAG-repeats in SCA2 and SCA7.
- Protocol for genetic testing in Huntington Disease: three years of experience in Minnesota.
- Diagnosis of Huntington Disease: model for a predictive testing program based on understanding the stages of psychological response.
- Smaller intracranial volume in prodromal Huntington''s Disease: evidence for abnormal neurodevelopment.
- Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.
- Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson''s Disease.
- Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer Disease and Parkinson Disease.
- Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia.
- Fine mapping and genetic heterogeneity in the pure form of autosomal dominant familial spastic paraplegia.
- Evidence for a modifier of onset age in Huntington Disease linked to the HD gene in 4p16.
- Clinical heterogeneity of familial spastic paraplegia linked to chromosome 2p21.
- A genome scan for modifiers of age at onset in Huntington Disease: The HD MAPS study.
- Challenges assessing clinical endpoints in early Huntington Disease.
- Striatal and white matter predictors of estimated diagnosis for Huntington Disease.
- Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22.
- Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington''s Disease.
- Detection of Huntington''s Disease decades before diagnosis: the Predict-HD study.
- Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's Disease families.
- Apolipoprotein E controls the risk and age at onset of Parkinson Disease.
- Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's Disease.
- The alpha-synuclein gene is not a major risk factor in familial Parkinson Disease.
Schools
Med College Of Virginia Hospitals
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- View All
Doctors Specialties
- Clinical Genetics
- Neurology
Accepted Insurances
Education
-
University of Minnesota at Fairview
Helpful Reviews
Similar Doctors
|
Dr. George Adam, MD |
|
|
Dr. Frederick R. Taylor, MD |
|
|
Dr. Eric C. Schenk, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel G. Freking, MD |
|
|
Dr. Leanore M. Simon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Drahomira Sencakova, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Teresa A. Tran-Lim, MD |
|
|
Dr. John M. Worley, DO |